Abuse-Deterrent OxyContin’s Benefit Unclear Years After Approval

Bookmark
(Bloomberg) -- A decade after Purdue Pharma LP changed OxyContin in an attempt to make it harder to abuse, U.S. health officials found there isn’t enough evidence to show an overall benefit.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.